| Price | $1.36 |
| Year Range | $0.51 – $2.22 |
| Market Cap | $26M |
| Industry | Biotechnology |
What Is Hoth Therapeutics’s AI Stock Analysis?
Hoth Therapeutics’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Hoth Therapeutics’s momentum in near-real time.
Hoth Therapeutics (HOTH) has an AltIndex AI Score of 46/100, currently a Hold signal. The AI Score distills Hoth Therapeutics's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Hoth Therapeutics’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Hoth Therapeutics — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving HOTH’s AI Score?
Fundamentals
Net income for the last quarter was $-2.7M. This represents a decrease of 0.16% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -22.54%, suggesting positive year-over-year growth. Ebitda for the last quarter was $-2.6M. This represents a decrease of 1.67% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -23.81%, suggesting positive year-over-year growth.
See Hoth Therapeutics’s earnings and insider transactions.
Technicals
The trend is bearish. The current SMA10 is $0.89, which is lower than the previous SMA10 of $0.90. This suggests a potential downward trend in price movement. The RSI is 30, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Hoth Therapeutics has an estimated 0 open positions and this number has been stable over the last couple of months indicating a company in a stable position. Hoth Therapeutics has an estimate of 4,000 visitors to their webpage, with no meaningful increase or decrese in the last couple of months.
Explore Hoth Therapeutics’s job postings, web traffic and app downloads.
Sentiment & social
However, the sentiment is down by -11% in the last couple of weeks, a worrisome trend.
Track Hoth Therapeutics’s market sentiment.
Frequently Asked Questions: Hoth Therapeutics AI Stock Analysis
Hoth Therapeutics's AltIndex AI Score is 46/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Hoth Therapeutics a Hold (46/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Hoth Therapeutics — company overview, fundamentals, technicals and alternative data, with a recommendation. See the HOTH AI Score or sign up to read the full thesis.
